Ageing influences the effect of pre-hypoxic administration of clonidine, an alpha 2-adrenoceptor agonist, on post-hypoxic vasomotricity

Journal of Physiology and Pharmacology

Volumn 63, Issue 2, 2012, Pages 165-171

  Gourdin, M J ^a,b   Ponchau, O ^b   Jamart, J ^a   de Kock, M ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

2 adrenoceptor; 2 adrenoceptor agonist; Ageing; Clonidine; Hypoxia reoxygenation; Simvastatin; Vascular

Indexed keywords

CLONIDINE; SIMVASTATIN;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM DEPENDENT DILATATION; HYPOXIA; MALE; NONHUMAN; RAT; REOXYGENATION; VASCULAR RING; VASOMOTOR REFLEX;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; AGING; ANIMALS; ANOXIA; AORTA, THORACIC; CLONIDINE; ENDOTHELIUM, VASCULAR; MALE; RATS; RATS, WISTAR; VASODILATION;

EID: 84861845248     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Garcia SC, Pomblum V, Gams E, Langenbach MR, Schipke JD. Independency of myocardial stunning of endothelial stunning? Basic Res Cardiol 2007; 102: 359-367.
2. Lefer AM, Tsao PS, Lefer DJ, Ma XL. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 1991; 5: 2029-2034.
3. Qi XL, Nguyen TL, Andries L, Sys SU, Rouleau JL. Vascular endothelial dysfunction contributes to myocardial depression in ischemia-reperfusion in the rat. Can J Physiol Pharmacol 1998; 76: 35-45.
4. Gourdin MJ, Ponchau O, Jamart J, De Kock M. Prehypoxic clonidine administration improves vasomotricity of isolated rat aorta during reoxygenation. Eur J Anaesthesiol 2010; 27: 965-972.
5. Dean JM, George S, Naylor AS, Mallard C, Gunn AJ, Bennet L. Partial neuroprotection with low-dose infusion of the alpha2-adrenergic receptor agonist clonidine after severe hypoxia in preterm fetal sheep. Neuropharmacology 2008; 55: 166-174.
6. Guo H, Takahashi S, Cho S, Hara T, Tomiyasu S, Sumikawa K. The effects of dexmedetomidine on left ventricular function during hypoxia and reoxygenation in isolated rat hearts. Anesth Analg 2005; 100: 629-635.
7. Laudenbach V, Mantz J, Lagercrantz H, Desmonts JM, Evrard P, Gressens P. Effects of alpha(2)-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology 2002; 96: 134-141.
8. Okada H, Kurita T, Mochizuki T, Morita K, Sato S. The cardioprotective effect of dexmedetomidine on global ischaemia in isolated rat hearths. Resuscitation 2007; 74: 538-545.
9. Solez K, Ideura T, Silvia CB, Hamilton B, Saito H. Clonidine after renal ischemia to lessen acute renal failure and microvascular damage. Kidney Int 1980; 18: 309-322.
10. Bursztyn M, Bresnahan M, Gavras I, Gavras H. Effect of aging on vasopressin, catecholamines, and alpha2-adrenergic receptors. J Am Geriatr Soc 1990; 38: 628-632.
11. Elliott HL, Sumner DJ, McLean K, Reid JL. Effect of age on the responsiveness of vascular alpha-adrenoceptors in man. J Cardiovasc Pharmacol 1982; 4: 388-392.
12. McAdams RP, Waterfall JF. The effect of age on the sensitivity of pre- and postsynaptic alpha-adrenoceptors to agonists and antagonists in the rat. Naunyn Schmiedebergs Arch Pharmacol 1986; 334: 430-435.
13. Schutzer WE, Xue H, Reed JF, Mader SL. Effect of age on vascular beta2-adrenergic receptor desensitization is not mediated by the receptor coupling to Galphai proteins. J Gerontol A Biol Sci Med Sci 2006; 61: 899-906.
14. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 2005; 66: 286-294.
15. Wojtovich AP, Nadtochiy SM, Brookes PS, Nehrke K. Ischemic preconditioning: the role of mitochondria and aging. Exp Gerontol 2012; 47: 1-7.
16. Pirogov AL, Al'tman DA, Ermak EM, Davydova EV. Pleiotropic effects of small dozes simvastatin in patients of senile age with chronic heart failure. Adv Gerontol 2009; 22: 356-363
17. Liu PY, Liu YW, Lin LJ, Chen JH, Lia JK. Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 2009; 119: 131-138.
18. de Sotomayor MA, Perez-Guerrero C, Herrrera MD, et al. Improvement of age-related endothelial dysfunction by simvastatin: effect on NO and COX pathways. Br J Pharmacol 2005; 146: 1130-1138.
19. Abdul Rahman MN, Chetter IC. Statins and ischaemia reperfusion injury: a molecular biological review. Curr Vasc Pharmacol 2010; 8: 831-835.
20. Besse S, Tanguy S, Riou B, et al. Coronary and aortic vasoreactivity protection with endothelin receptor antagonist, bosentan, after ischemia and hypoxia in aged rats. Eur J Pharmacol 2001; 432: 167-175.
21. Slijper N, Sukhotnik I, Chemodanov E, et al. Effect of simvastatin on intestinal recovery following gut ischemia-reperfusion injury in a rat. Pediatr Surg Int 2010; 26: 105-110.
22. Alcindor D, Krolikowski J G, Pagel PS, Warltier DC, Kersten JR. Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo. Anesthesiology 2004; 100: 547-554.
23. Birnbaum Y, Ye Y, Rosanio S, et al. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. Cardiovasc Res 2005; 65: 345-355.
24. Cuong DV, Kim N, Youm JB, et al. Nitric oxide-cGMP-protein kinase G signaling pathway induces anoxic preconditioning through activation of ATP-sensitive K+ channels in rat hearts. Am J Physiol Heart Circ Physiol 2006; 290: H1808-H1817.
25. Han J, Kim N, Joo H, Kim E, Earm YE. ATP-sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 2002; 283: H1545-H1554.
26. Tosaka S, Tosaka R, Matsumoto S, Maekawa T, Cho S, Sumikawa K. Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts. J Cardiovasc Pharmacol Ther 2011; 16: 72-78.
27. Yildiz O. Vascular smooth muscle and endothelial functions in aging. Ann NY Acad Sci 2007; 1100: 353-360.
28. Csiszar A, Pacher P, Kaley G, Ungvari Z. Role of oxidative and nitrosative stress, longevity genes and poly(ADP-ribose) polymerase in cardiovascular dysfunction associated with aging. Curr Vasc Pharmacol 2005; 3: 285-291.
29. Singh N, Prasad S, Singer SR, MacAllister RJ. Ageing is associated with impairment of nitric oxide and prostanoid dilator pathways in the human forearm. Clin Sci 2002; 102: 595-600.
30. Feletou M, Cohen R, Vanhoutte P, Verbeuren T. TP Receptors and oxidative stress: hand in hand from endothelial dysfunction to atherosclerosis. Adv Pharmacol 2010; 60: 85-106.
31. Gendron M, Thorin E. A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in mice. Am J Physiol Heart Circ Physiol 2007; 293: H2508-H2515.
32. Sharyo S, Yokota-Ikeda N, Mori M, et al. Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway. Kidney Int 2008; 74: 577-584.
33. Yokota N, O'Donnell M, Daniels F, et al. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol 2003; 23: 13-17.
34. Harris M, Blackstone M, Sood S, et al. Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Am J Physiol Heart Circ Physiol 2004; 287: H560-H566.
35. 2+ overload in cardiac myocytes via modulation of the diastolic membrane potential. Br J Pharmacol 2004; 141: 1059-1067.
36. Cipolla MJ, Smith J, Kohlmeyer MM, Godfrey JA. SKCa and IKCa channels, myogenic tone, and vasodilator responses in middle cerebral arteries and parenchymal arterioles: effect of ischemia and reperfusion. Stroke 2009; 40: 1451-1457.
37. Gao H, Chen L, Yang HT. Activation of alpha1β-adrenoceptors alleviates ischemia/reperfusion injury by limitation of mitochondrial Ca2+ overload in cardiomyocytes. Cardiovasc Res 2007; 75: 584-595.
38. Alvarez de Sotomayor M, Vega S, Mingorance C, Marhuenda E, Herrera MD. Effects of HMG-CoA reductase inhibition by simvastatin on vascular dysfunction induced by lipopolysaccharide in rats. Pharmacology 2008; 82: 89-96.
39. 2+ homeostasis. Eur J Pharmacol 2001; 415: 217-224.